Inventor
WANG CHIA-LIN J
US15 patents
⚠️ This page may combine multiple inventors who share the name “WANG CHIA-LIN J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DU PONT
8 patentsUS4801600AJan 31, 1989
Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
DU PONT61 citations95
US4965268AOct 23, 1990
Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
DU PONT24 citations92
US4921869AMay 1, 1990
Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
DU PONT45 citations92
US4803272AFeb 7, 1989
S-modified adenosyl-1,8-diamino-3-thiooctane derivatives
DU PONT32 citations92
US4486445ADec 4, 1984
Justicidin insecticidal and antiviral compounds
DU PONT27 citations86
US4985429AJan 15, 1991
Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
DU PONT10 citations73
US4456613AJun 26, 1984
6-Keto- and 6-hydroxy-8-azaprostanoids and anti-ulcer use thereof
DU PONT15 citations73
US4530933AJul 23, 1985
8-Aza-13-thiaprostanoids and a method of use thereof as anti-ulcer agents
DU PONT0 citations51
DU PONT MERCK PHARMA
4 patentsUS5039690AAug 13, 1991
Aminomethyl oxooxazolidinyl oxa or thia cycloalkylbenzene derivatives useful as antibacterial agents
DU PONT MERCK PHARMA12 citations73
US5036092AJul 30, 1991
Aminomethyl oxooxazolidinyl azacycloalkylbenzene derivatives useful as antibacterial agents
DU PONT MERCK PHARMA14 citations73
US5036093AJul 30, 1991
Aminomethyl oxooxazolidinyl azacycloalkylbenzene derivatives useful as antibacterial agents
DU PONT MERCK PHARMA7 citations73
US5032605AJul 16, 1991
Aminomethyl oxooxazolidinyl oxa or thia cycloalkylbenzene derivatives useful as antibacterial agents
DU PONT MERCK PHARMA11 citations73
DEV CT BIOTECHNOLOGY
3 patentsUS5840991ANov 24, 1998
Antiatherosclerosis agents for lipid-lowering and antiperoxidative activity
DEV CT BIOTECHNOLOGY8 citations68
US5710280AJan 20, 1998
Preparation of fluconazole and pharmaceutically acceptable salts thereof
DEV CT BIOTECHNOLOGY14 citations66
US5504221AApr 2, 1996
Method for resolving racemic compounds
DEV CT BIOTECHNOLOGY2 citations57